Skip to content

Author

Yu-Hong Li

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Real-world comparative effectiveness of neoadjuvant chemoimmunotherapy versus chemotherapy for locally advanced esophageal squamous cell carcinoma: a retrospective cohort study

Neoadjuvant chemoimmunotherapy (NCIT) has shown higher pathologic response rates than neoadjuvant chemotherapy (NCT) in patients with locally advanced esophageal squamous cell carcinoma (LA-ESCC). Recent studies have reported comparative survival outcomes, but evidence from extended follow-up remains limited....

Y. Ao, Chang-Sen Leng, Kong-Jia Luo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.